Logo image of NAD

NUVEEN QUALITY MUNICIPAL INC (NAD) Stock Price, Quote, News and Overview

NYSE:NAD - New York Stock Exchange, Inc. - US67066V1017 - Currency: USD

11.41  0 (0%)

Fundamental Rating

3

Taking everything into account, NAD scores 3 out of 10 in our fundamental rating. NAD was compared to 0 industry peers in the Unkown industry. NAD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NAD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year NAD was profitable.
NAD had a positive operating cash flow in the past year.
NAD had positive earnings in 4 of the past 5 years.
NAD had a positive operating cash flow in each of the past 5 years.
NAD Yearly Net Income VS EBIT VS OCF VS FCFNAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M -800M

1.2 Ratios

Industry RankSector Rank
ROA 9.9%
ROE 10.14%
ROIC 1.85%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NAD Yearly ROA, ROE, ROICNAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

NAD's Profit Margin has been stable in the last couple of years.
NAD's Operating Margin has declined in the last couple of years.
NAD's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 48.25%
PM (TTM) 204.82%
GM 47.81%
OM growth 3Y-14.2%
OM growth 5Y-5.66%
PM growth 3Y23.91%
PM growth 5Y0.05%
GM growth 3Y-14.27%
GM growth 5Y-5.74%
NAD Yearly Profit, Operating, Gross MarginsNAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200 -300

More info and screens

5

2. Health

2.1 Basic Checks

There is no outstanding debt for NAD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NAD Yearly Shares OutstandingNAD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
NAD Yearly Total Debt VS Total AssetsNAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

NAD has an Altman-Z score of 14.50. This indicates that NAD is financially healthy and has little risk of bankruptcy at the moment.
The Debt to FCF ratio of NAD is 0.96, which is an excellent value as it means it would take NAD, only 0.96 years of fcf income to pay off all of its debts.
NAD has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Although NAD does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.96
Altman-Z 14.5
ROIC/WACCN/A
WACCN/A
NAD Yearly LT Debt VS Equity VS FCFNAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

NAD has a Current Ratio of 2.82. This indicates that NAD is financially healthy and has no problem in meeting its short term obligations.
NAD has a Quick Ratio of 2.82. This indicates that NAD is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.82
Quick Ratio 2.82
NAD Yearly Current Assets VS Current LiabilitesNAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 952.63% over the past year.
NAD shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.25% yearly.
NAD shows a small growth in Revenue. In the last year, the Revenue has grown by 2.09%.
NAD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.65% yearly.
EPS 1Y (TTM)952.63%
EPS 3Y26.41%
EPS 5Y-1.25%
EPS Q2Q%132.58%
Revenue 1Y (TTM)2.09%
Revenue growth 3Y2.07%
Revenue growth 5Y1.65%
Sales Q2Q%3.73%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NAD Yearly Revenue VS EstimatesNAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 5.71, which indicates a rather cheap valuation of NAD.
NAD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.45.
Industry RankSector Rank
PE 5.71
Fwd PE N/A
NAD Price Earnings VS Forward Price EarningsNAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 31.7
EV/EBITDA N/A
NAD Per share dataNAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.94%, NAD is a good candidate for dividend investing.
NAD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 7.94%

5.2 History

The dividend of NAD decreases each year by -6.94%.
NAD has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of NAD decreased recently.
Dividend Growth(5Y)-6.94%
Div Incr Years1
Div Non Decr Years1
NAD Yearly Dividends per shareNAD Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

33.62% of the earnings are spent on dividend by NAD. This is a low number and sustainable payout ratio.
NAD's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP33.62%
EPS Next 2YN/A
EPS Next 3YN/A
NAD Yearly Income VS Free CF VS DividendNAD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M -800M
NAD Dividend Payout.NAD Dividend Payout, showing the Payout Ratio.NAD Dividend Payout.PayoutRetained Earnings

More info and screens

NUVEEN QUALITY MUNICIPAL INC

NYSE:NAD (7/3/2025, 7:52:10 PM)

11.41

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)07-01 2025-07-01
Earnings (Next)N/A N/A
Inst Owners27.98%
Inst Owner Change-9.72%
Ins Owners0.02%
Ins Owner Change0.69%
Market Cap2.66B
Analysts0
Price TargetN/A
Short Float %0.19%
Short Ratio0.53
Dividend
Industry RankSector Rank
Dividend Yield 7.94%
Yearly Dividend0.49
Dividend Growth(5Y)-6.94%
DP33.62%
Div Incr Years1
Div Non Decr Years1
Ex-Date06-13 2025-06-13 (0.0755)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.71
Fwd PE N/A
P/S 11.68
P/FCF 31.7
P/OCF 31.7
P/B 0.58
P/tB 0.58
EV/EBITDA N/A
EPS(TTM)2
EY17.53%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.36
FCFY3.15%
OCF(TTM)0.36
OCFY3.15%
SpS0.98
BVpS19.74
TBVpS19.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.9%
ROE 10.14%
ROCE 2.35%
ROIC 1.85%
ROICexc 1.85%
ROICexgc 1.85%
OM 48.25%
PM (TTM) 204.82%
GM 47.81%
FCFM 36.84%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-14.2%
OM growth 5Y-5.66%
PM growth 3Y23.91%
PM growth 5Y0.05%
GM growth 3Y-14.27%
GM growth 5Y-5.74%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.96
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.34
Cash Conversion N/A
Profit Quality 17.99%
Current Ratio 2.82
Quick Ratio 2.82
Altman-Z 14.5
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)952.63%
EPS 3Y26.41%
EPS 5Y-1.25%
EPS Q2Q%132.58%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.09%
Revenue growth 3Y2.07%
Revenue growth 5Y1.65%
Sales Q2Q%3.73%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.7%
EBIT growth 3Y-12.43%
EBIT growth 5Y-4.1%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-53.98%
FCF growth 3Y-18.8%
FCF growth 5Y-8.41%
OCF growth 1Y-53.98%
OCF growth 3Y-18.8%
OCF growth 5Y-8.41%